Essex Investment Management’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.31M | Sell |
50,004
-1,405
| -3% | -$126K | 0.68% | 47 |
|
|
2025
Q4 | $4.49M | Sell |
51,409
-1,215
| -2% | -$92.2K | 0.68% | 48 |
|
|
2025
Q3 | $3.01M | Sell |
52,624
-1,912
| -4% | -$110K | 0.46% | 83 |
|
|
2025
Q2 | $3.22M | Sell |
54,536
-1,441
| -3% | -$93.1K | 0.59% | 63 |
|
|
2025
Q1 | $4.1M | Sell |
55,977
-7,968
| -12% | -$658K | 0.85% | 30 |
|
|
2024
Q4 | $5.29M | Sell |
63,945
-2,041
| -3% | -$161K | 0.95% | 24 |
|
|
2024
Q3 | $4.72M | Sell |
65,986
-3,910
| -6% | -$276K | 0.82% | 39 |
|
|
2024
Q2 | $4.79M | Sell |
69,896
-9,024
| -11% | -$539K | 0.9% | 30 |
|
|
2024
Q1 | $4.23M | Sell |
78,920
-9,284
| -11% | -$499K | 0.84% | 35 |
|
|
2023
Q4 | $4.7M | Sell |
88,204
-60,502
| -41% | -$2.95M | 0.93% | 24 |
|
|
2023
Q3 | $7.38M | Sell |
148,706
-4,878
| -3% | -$273K | 1.21% | 11 |
|
|
2023
Q2 | $9.14M | Buy |
153,584
+95,088
| +163% | +$5.42M | 1.28% | 9 |
|
|
2023
Q1 | $3.31M | Buy |
58,496
+3,470
| +6% | +$223K | 0.48% | 64 |
|
|
2022
Q4 | $4.09M | Buy |
55,026
+5,966
| +12% | +$406K | 0.64% | 42 |
|
|
2022
Q3 | $2.92M | Buy |
49,060
+5,021
| +11% | +$302K | 0.47% | 68 |
|
|
2022
Q2 | $2.47M | Sell |
44,039
-3,370
| -7% | -$222K | 0.4% | 75 |
|
|
2022
Q1 | $3.5M | Buy |
47,409
+21,557
| +83% | +$1.5M | 0.44% | 62 |
|
|
2021
Q4 | $1.87M | Sell |
25,852
-699
| -3% | -$50.7K | 0.21% | 150 |
|
|
2021
Q3 | $2.03M | Sell |
26,551
-15,394
| -37% | -$1.24M | 0.25% | 130 |
|
|
2021
Q2 | $3.25M | Sell |
41,945
-11,116
| -21% | -$790K | 0.38% | 86 |
|
|
2021
Q1 | $3.27M | Sell |
53,061
-1,898
| -3% | -$120K | 0.4% | 74 |
|
|
2020
Q4 | $3.58M | Buy |
54,959
+32,766
| +148% | +$1.88M | 0.44% | 69 |
|
|
2020
Q3 | $1.1M | Sell |
22,193
-277
| -1% | -$14.3K | 0.16% | 205 |
|
|
2020
Q2 | $1.07M | Sell |
22,470
-1,303
| -5% | -$62.9K | 0.18% | 188 |
|
|
2020
Q1 | $1.01M | Buy |
23,773
+409
| +2% | +$20.2K | 0.2% | 155 |
|
|
2019
Q4 | $1.38M | Buy |
23,364
+5,121
| +28% | +$278K | 0.17% | 192 |
|
|
2019
Q3 | $933K | Buy |
18,243
+2,142
| +13% | +$102K | 0.13% | 224 |
|
|
2019
Q2 | $681K | Sell |
16,101
-18,270
| -53% | -$793K | 0.09% | 271 |
|
|
2019
Q1 | $1.7M | Sell |
34,371
-187
| -0.5% | -$8.46K | 0.25% | 127 |
|
|
2018
Q4 | $1.5M | Buy |
34,558
+4,270
| +14% | +$213K | 0.23% | 134 |
|
|
2018
Q3 | $1.72M | Buy |
30,288
+14,649
| +94% | +$771K | 0.2% | 157 |
|
|
2018
Q2 | $789K | Buy |
+15,639
| New | +$816K | 0.1% | 249 |
|
|
2014
Q3 | – | Sell |
-14,370
| Closed | -$344K | – | 369 |
|
|
2014
Q2 | $344K | Buy |
+14,370
| New | +$347K | 0.05% | 280 |
|
Other funds holding GMED
VCM
VPM
SC
Essex Investment Management's GMED Position: Q1 2026 in Review
Essex Investment Management reduced its Globus Medical (GMED) stake by 2.7% in Q1 2026, selling an estimated $126K and leaving 50,004 shares worth $4.31M. The position accounts for 0.68% of the portfolio, ranked #47.
Essex Investment Management first reported a position in GMED in Q2 2014 and has held it in 33 quarters since. The position peaked at $9.14M in Q2 2023. 605 funds tracked by Wall St. Rank hold GMED as of Q1 2026.
- Essex Investment Management held 50,004 shares of Globus Medical worth $4.31M as of Q1 2026.
- Essex Investment Management sold 1,405 Globus Medical shares in Q1 2026, an estimated $126K.
- Globus Medical made up 0.68% of Essex Investment Management's portfolio in Q1 2026, its #47 holding.
- Essex Investment Management first reported a position in Globus Medical in Q2 2014 and has held it in 33 quarters since.
- Essex Investment Management's Globus Medical position peaked at $9.14M in Q2 2023.
- 605 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.
Based on Essex Investment Management's 13F filing for Q1 2026, filed 11 May 2026.